Acute Rheumatic Fever and Rheumatic Heart Disease in Children and Adolescents in Victoria, Australia
Overview
Authors
Affiliations
Aim: To describe the epidemiology and clinical profile of children and adolescents with acute rheumatic fever (ARF) and rheumatic heart disease (RHD) in Victoria, Australia.
Methods: A retrospective audit was undertaken of children and adolescents with ARF and RHD attending the Royal Children's and Monash Children's Hospitals in Victoria, Australia between 2010 and 2019. Potential cases were identified by searching multiple sources for relevant ICD-10-AM codes and keywords, then reviewed manually. For confirmed cases, we collected data on patient demographics, clinical features, comorbidities and management.
Results: Of 179 participants included, there were 108 Victorian residents and 71 non-Victorian residents. 126 had at least one episode of ARF during the study period and 128 were diagnosed with RHD. In the Victorian resident group, the overall incidence of ARF was 0.8 per 100 000 5-14 year olds. This incidence was higher in Victorian Aboriginal and/or Torres Strait Islander (3.8 per 100 000) and Pacific Islander (32.1 per 100 000) sub-populations. Of 83 Victorian residents who had an ARF episode, 11 (13%) had a recurrence. Most Victorian residents with RHD had mixed aortic and mitral valve pathology (69.4%) and moderate to severe disease (61.9%). Most non-Victorian residents were Aboriginal and/or Torres Strait Islander people (80.3%) and were commonly transferred for tertiary or surgical management of RHD (83.1%).
Conclusions: ARF and RHD continue to affect the health of significant numbers of children and adolescents living in Victoria, including severe and recurrent disease. Specialised services and a register-based control program may help to prevent complications and premature death.
Risk Factors for Acute Rheumatic Disease: Exploring Factors at Individual and Collective Levels.
Mendoza R, Mutarelli A, Mendoza B, Barbosa J, Oliveira R, Nascimento B Rev Soc Bras Med Trop. 2024; 57.
PMID: 39570153 PMC: 11654748. DOI: 10.1590/0037-8682-0139-2024.
Living with rheumatic fever and rheumatic heart disease in Victoria, Australia: A qualitative study.
Oliver J, Fualautoalasi-Lam L, Ferdinand A, Tiatia R, Jones B, Engelman D PLoS Negl Trop Dis. 2024; 18(8):e0012038.
PMID: 39213445 PMC: 11392276. DOI: 10.1371/journal.pntd.0012038.
Carville K, Meagher N, Abo Y, Manski-Nankervis J, Fielding J, Steer A BMC Prim Care. 2024; 25(1):117.
PMID: 38632513 PMC: 11022400. DOI: 10.1186/s12875-024-02371-y.
Recent Scientific Advancements towards a Vaccine against Group A .
Fan J, Toth I, Stephenson R Vaccines (Basel). 2024; 12(3).
PMID: 38543906 PMC: 10974072. DOI: 10.3390/vaccines12030272.
Current Clinical Profile of Acute Rheumatic Fever and Recurrent Acute Rheumatic Fever in Pakistan.
Sadiq N, Afshan G, Qureshi A, Sadiq M Pediatr Cardiol. 2023; 45(2):240-247.
PMID: 38148410 DOI: 10.1007/s00246-023-03378-5.